| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/19/1999 | CA2320193A1 Controlled release preparation |
| 08/19/1999 | CA2320132A1 Pressure sensitive adhesive matrix patch for the treatment of onychomycosis |
| 08/19/1999 | CA2320044A1 Treatment of multiple sclerosis using cop-1 and th2-enhancing cytokines |
| 08/19/1999 | CA2319740A1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
| 08/18/1999 | EP0935616A1 Adhesives with low level of residual monomers and process for manufacturing same |
| 08/18/1999 | EP0935523A1 Embedding and encapsulation of controlled release particles |
| 08/18/1999 | EP0935470A1 Method for treating allergic lung disease |
| 08/18/1999 | EP0935460A1 Taste masked pharmaceutical compositions |
| 08/18/1999 | EP0935459A1 Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix |
| 08/18/1999 | EP0935458A1 Compositions containing at least one nucleic acid |
| 08/18/1999 | EP0935457A1 Preparation for the transport of an active substance across barriers |
| 08/18/1999 | EP0935425A1 Fat-coated encapsulation compositions and method for preparing the same |
| 08/18/1999 | EP0935417A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/18/1999 | EP0804152B1 Lactulose lozenges |
| 08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/18/1999 | EP0770053B1 Positive photoactive compounds based on 2,6-dinitrobenzyl groups |
| 08/18/1999 | EP0766556B1 Volume-expandable flat article suitable for use as an active substance carrier, in particular for oral use |
| 08/18/1999 | EP0762899A4 Stabilized homogenous suspensions as computed tomography contrast agents |
| 08/18/1999 | EP0756489B1 Cyclosporin containing composition and process for the preparation thereof |
| 08/18/1999 | EP0697869B1 Transdermal therapeutic systems for the administration of serotonin agonists |
| 08/18/1999 | EP0675709B1 Freeze-dried emulsion containing an active substance |
| 08/18/1999 | EP0642334B1 Pharmaceutical and other dosage forms |
| 08/18/1999 | CN1226166A Formulation and method for treating congestive heart failure |
| 08/18/1999 | CN1226165A Method for treating bipolar disorder |
| 08/18/1999 | CN1226163A Formulation for treatment and/or prevention of dementia |
| 08/18/1999 | CN1226162A Coated trimebutine maleate tablet |
| 08/18/1999 | CN1226160A Device for topical treatment of acne and its method of manufacture |
| 08/18/1999 | CN1226152A Transdermal propentofylline compositions for treatment of alzheimer's disease |
| 08/18/1999 | CN1226132A Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 08/18/1999 | CN1225842A Wet-dressing agent |
| 08/18/1999 | CN1225835A Oil-state fine medicinal powder preparation for treating carbuncle, sore and preparation method therefor |
| 08/18/1999 | CN1225824A Diagnosis and treatment and health-care medicinal liquor of external use for the five sense organs |
| 08/18/1999 | CN1225820A Preparation method for honeybee placenta element and honeybee cocoon element, and use thereof |
| 08/18/1999 | CN1225815A Dried lipid article and preparation method therefor |
| 08/18/1999 | CN1044709C Method for crystallizing itnerferon alpha-2 |
| 08/18/1999 | CN1044678C Oxo-phosphoric acid suspension production method |
| 08/18/1999 | CN1044668C Vegetable oil composition |
| 08/17/1999 | US5939567 Reacting stoiochiometric amount of fatty acid chloride or anhydride with taxane to attach the hydrocarbon chain to the hydroxy group at position 2' of taxane |
| 08/17/1999 | US5939536 Methods for purifying cystic fibrosis transmembrane conductance regulation |
| 08/17/1999 | US5939466 Contact lenses; drug delivery |
| 08/17/1999 | US5939453 PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers |
| 08/17/1999 | US5939427 Lotion with 17-allyl-1,4-dihydroxy-12-(2-(4-hydroxy-3-methoxy cyclohexyl)-1-methylvinyl)-23,25-dimethoxy-13,19,21,27-tetrame thyl-11,28-dioxa-4-azatricyclo(22.3.1.0(4,9))octacos-18-ene-1, 3,10,16-tetraone or salt as antiinflammatory agent |
| 08/17/1999 | US5939401 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 08/17/1999 | US5939394 Treatment of allergies and autoimmune diseases, antioxidants and magnesium gluconate |
| 08/17/1999 | US5939381 4-(4-(phenoxyacetyl)aminophenyl)butyric acid as a carrier for drug delivery |
| 08/17/1999 | US5939380 Bioerosion preparation for implants with sustained action of polypeptides with lipid powders |
| 08/17/1999 | US5939100 Diminishing the desire of a subject to use tobacco by administering thepowdery pharmaceutical microspheres |
| 08/17/1999 | US5939099 Solid active extrusion compound preparations containing low-substituted hydroxypropylcellulose |
| 08/17/1999 | US5939097 Food-like medicine |
| 08/17/1999 | US5939096 Stably encapsulating a weak acid drug in liposomes, at a high concentration |
| 08/17/1999 | US5939095 At least one parasympathomimetically active substance and at least one parasympatholytically active substance |
| 08/17/1999 | US5939094 Dosage form |
| 08/17/1999 | US5939091 Method for making fast-melt tablets |
| 08/17/1999 | US5939090 Gel formulations for topical drug delivery |
| 08/17/1999 | US5939084 Containing glycol to dissolve melatonin; prevention of oxidative stress |
| 08/17/1999 | US5939047 Local delivery of chemotherapeutic agents for treatment of periodontal disease |
| 08/17/1999 | US5938990 Encapsulation of oleophilic substances and compositions produced thereby |
| 08/17/1999 | US5938923 Microfabricated filter and capsule using a substrate sandwich |
| 08/17/1999 | US5938915 Electrolyzing raw water to generate purified proton-rich water in cathode compartment, administering cathode water to patient's blood to reduce oxyanion radicals present in blood |
| 08/17/1999 | US5938654 Osmotic device for delayed delivery of agent |
| 08/17/1999 | CA2214106C Film-enrobed, unitary-core medicament and the like |
| 08/17/1999 | CA2152262C Process to prepare pharmaceutical compositions containing vecuronium bromide |
| 08/17/1999 | CA2151575C Cosmetic composition containing a fatty substance and a polymeric aqueous dispersion and use of said substance |
| 08/17/1999 | CA2150870C Cosmetic sunscreens and their uses |
| 08/17/1999 | CA2105180C Compositions containing sumatriptan |
| 08/17/1999 | CA2098738C Controlled release oxycodone compositions |
| 08/17/1999 | CA2042722C Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| 08/16/1999 | CA2247994A1 Solubilizing delivery systems and method of manufacture |
| 08/16/1999 | CA2247877A1 Solubilizing delivery systems and method of manufacture |
| 08/12/1999 | WO1999040156A1 Alkylene oxide polymer compositions |
| 08/12/1999 | WO1999040153A1 Acid-stable and cationic-compatible cellulose compositions and methods of preparation |
| 08/12/1999 | WO1999040113A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions |
| 08/12/1999 | WO1999040031A2 Water purification apparatus |
| 08/12/1999 | WO1999039756A2 Supporting material for medicinal purposes |
| 08/12/1999 | WO1999039742A1 Liposome fusion and delivery vehicle |
| 08/12/1999 | WO1999039741A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 08/12/1999 | WO1999039740A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 08/12/1999 | WO1999039738A1 Targeted delivery of biologically active media |
| 08/12/1999 | WO1999039731A1 Copolymer compositions for oral delivery |
| 08/12/1999 | WO1999039724A1 Treatment of bony defects with osteoblast precursor cells |
| 08/12/1999 | WO1999039717A1 Pharmaceutical composition for nasal administration of thiocolchicoside |
| 08/12/1999 | WO1999039713A1 Piroxicam-containing hydroalcoholic gel composition |
| 08/12/1999 | WO1999039709A1 Liquid pharmaceutical formulation containing zotepine |
| 08/12/1999 | WO1999039708A1 Tablets to be crunched or sucked, comprising iron as active principle |
| 08/12/1999 | WO1999039706A1 Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy |
| 08/12/1999 | WO1999039701A1 Device for releasing substances |
| 08/12/1999 | WO1999039700A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process |
| 08/12/1999 | WO1999039699A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract |
| 08/12/1999 | WO1999039698A1 Sustained release formulation |
| 08/12/1999 | WO1999039697A1 Method for ultrasound triggered drug delivery |
| 08/12/1999 | WO1999039696A1 Propofol composition containing sulfite |
| 08/12/1999 | WO1999039695A1 Emulsion for transdermal administration of an active principle |
| 08/12/1999 | WO1999039694A2 Compositions containing organic compounds |
| 08/12/1999 | WO1999039693A2 Methods and compositions for detection and diagnosis of infectious diseases |
| 08/12/1999 | WO1999039692A2 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 08/12/1999 | WO1999039691A2 Pharmaceutical compositions |
| 08/12/1999 | WO1999039686A1 Composition for the treatment of halitosis |
| 08/12/1999 | WO1999039580A1 Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 08/12/1999 | WO1999029298A3 Device for enhancing transdermal agent flux |